Shownotes
In traditional chemical manufacturing, multiple chemical reactions must take place before the desired final product is achieved. Even then, purity and yield can be extremely low. Biological processes can be complex and produce unwanted by-products. However, removing the cell entirely could offer a way forward and reduce the time from idea to market.
In this episode of Balancing the Future, Chai speaks with Damien Perriman, Chief Commercial Officer at eXoZymes, a biotechnology company developing cell-free biomanufacturing platforms using AI and bioengineered enzymes.
Typically, enzymes…
Website: share.transistor.fm

